Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication (Q40728309)

23 September 2017

title

Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication (English)

1 reference

23 September 2017

0 references

4

0 references

Joao Goncalves

1

0 references

Rui Malhó

5

0 references

Carlos Barbas

8

object named as

Carlos Barbas

1 reference

23 September 2017

Frederico Silva

2

1 reference

23 September 2017

Acilino Freitas-Vieira

3

1 reference

23 September 2017

Xiaoyu Yang

6

1 reference

23 September 2017

Dana Gabuzda

7

1 reference

23 September 2017

language of work or name

English

0 references

publication date

30 May 2002

1 reference

Journal of Biological Chemistry

23 September 2017

published in

1 reference

23 September 2017

volume

277

1 reference

23 September 2017

issue

35

1 reference

23 September 2017

page(s)

32036-32045

1 reference

Cell-free transmission of Vif mutants of HIV-1

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

The sor gene of HIV-1 is required for efficient virus transmission in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

The HIV 'A' (sor) gene product is essential for virus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Role of vif during packing of the core of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Role of Vif in stability of the human immunodeficiency virus type 1 core

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Pseudotyping human immunodeficiency virus type 1 by vesicular stomatitis virus G protein does not reduce the cell-dependent requirement of vif for optimal infectivity: functional difference between Vif and Nef.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Phosphorylation of Vif and its role in HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

HIV accessory proteins: multifunctional components of a complex system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Identification of a nuclear transport inhibitory signal (NTIS) in the basic domain of HIV-1 Vif protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

The multimerization of human immunodeficiency virus type I Vif protein: a requirement for Vif function in the viral life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Fully functional, naturally occurring and C-terminally truncated variant human immunodeficiency virus (HIV) Vif does not bind to HIV Gag but influences intermediate filament structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

HIV-1: fifteen proteins and an RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

HIV accessory proteins as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Making antibodies by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Mitogen-activated protein kinase phosphorylates and regulates the HIV-1 Vif protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Production of high-titer helper-free retroviruses by transient transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Evidence for a newly discovered cellular anti-HIV-1 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

Correlation between in Vitro Stability and in Vivo Performance of Anti-GCN4 Intrabodies as Cytoplasmic Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M201906200

21 January 2018

Identifiers

DOI

10.1074/JBC.M201906200

1 reference

23 September 2017

1 reference